Alkem Laboratories
ALKEM.NSPhase 3Alkem Laboratories is a prominent Indian pharmaceutical company founded in 1973, headquartered in Mumbai. The company has established itself as a market leader in several therapeutic segments in India while expanding its international footprint across emerging markets. With a robust manufacturing infrastructure and strong R&D capabilities, Alkem focuses on developing affordable, high-quality generic and branded pharmaceutical products.
ALKEM.NS · Stock Price
Historical price data
AI Company Overview
Alkem Laboratories is a prominent Indian pharmaceutical company founded in 1973, headquartered in Mumbai. The company has established itself as a market leader in several therapeutic segments in India while expanding its international footprint across emerging markets. With a robust manufacturing infrastructure and strong R&D capabilities, Alkem focuses on developing affordable, high-quality generic and branded pharmaceutical products.
Technology Platform
Develops branded and complex generics with expertise in specialized formulation technologies across multiple therapeutic areas, particularly gastroenterology and women's health products.
Pipeline Snapshot
33 drugs in pipeline, 1 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| ENZ215 + Prolia | Postmenopausal Osteoporosis | Phase 3 | |
| BSG005 | Invasive Fungal Infection | Phase 1/2 | |
| ENZ215 + EU Sourced Prolia + US Sourced Prolia | Healthy Male Subjects | Phase 1 |
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with Sun Pharma, Lupin, Dr. Reddy's, and Cipla but differentiates through strong gastroenterology franchise and focus on emerging markets rather than regulated markets.
Company Info
Trading
Contact
Therapeutic Areas
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile